Walmart's $50 million opioid settlement with federal regulators

Key developments

1. Aug 31, 2026

   The DOJ and DEA announce Walmart will pay $50 million to settle allegations its pharmacies dispensed thousands of invalid opioid prescriptions dating back to 2013.

   7 sources on this →
2. Aug 31, 2026

   Walmart's settlement, which includes new compliance measures like a reporting hotline, resolves the case in Delaware federal court without an admission of liability.

   28 sources on this →

Coverage across the spectrum

Stories in this storyline

AI illustration

Business

Walmart Opioid Settlement Reaches $50 Million

The Department of Justice and Drug Enforcement Administration announced Walmart will pay 50 million dollars to settle federal allegations that its pharmacies dispensed thousands of invalid opioid and other controlled-substance prescriptions dating back to 2013, with new oversight measures including a reporting hotline and active monitoring of prescriptions. Walmart did not admit liability as part of the agreement, which includes strengthened compliance requirements to curb future violations.

7 sources

Photo: Jose Ismael Espinola / Wikimedia Commons (Pexels)

Business

Walmart Reaches $50 Million Opioid Settlement

Walmart has settled a U.S. government lawsuit accusing it of unlawfully dispensing opioids from its pharmacies, with the terms undisclosed and the case dismissed in federal court in Delaware; the Justice Department said the settlement resolves allegations of noncompliance with the Controlled Substances Act. The deal follows Walmart's 2022 $3.1 billion settlement with state and local governments over its role in the opioid crisis, as nationwide overdose deaths from opioid misuse continue to be a central issue and the financial impact remains unclear.